Is Your Research Involving Human Subjects Eligible for Exemption? John M. Falletta, M.D. Professor of Pediatrics Senior Chairman, DUHS IRB

Size: px
Start display at page:

Download "Is Your Research Involving Human Subjects Eligible for Exemption? John M. Falletta, M.D. Professor of Pediatrics Senior Chairman, DUHS IRB"

Transcription

1 Is Your Research Involving Human Subjects Eligible for Exemption? John M. Falletta, M.D. Professor of Pediatrics Senior Chairman, DUHS IRB

2 Exemption From What??and/or By Whom? Scrutiny by anyone? SBR review? CRSO review? CTQA audit? IRB review?

3 Considerations To Be Made Does your project involve: Research? Human Subjects? If so, is it eligible for exemption from further IRB review? If not, is DUHS, its employees or agents to be engaged in research with humans? If so, is it eligible for expedited review?

4 Definition of Research Common Rule: 45 CFR (d) HIPAA: 45 CFR A systematic investigation designed to develop or contribute to generalizable knowledge.

5 Definition of a Human Subject Common Rule: 45 CFR (f) A living individual about whom an investigator...conducting research obtains (1) data through intervention or interaction with the individual, or (2) identifiable private information.

6 Considerations To Be Made Does your project involve: Research? Human Subjects? If so, is it eligible for exemption from further IRB review? If not, is DUHS, its employees or agents to be engaged in research with humans? If so, is it eligible for expedited review?

7 Who Decides? DUHS HRPP Policy: When an activity is determined to be Research Involving Human Subjects, the investigator must submit the research for initial review by the DUHS IRB. Your Option: If you think your protocol meets one or more exemption criteria, please do request exemption.

8 When Requesting Exemption, You and the IRB must determine: Whether your research is subject to the Common Rule (45 CFR 46 Subpart A) Whether your research is subject to FDA regulations (21 CFR 50, 56, 312, 812) Does it involve the use of a non-fda-approved drug, device or biologic? Does it involve the use of an FDA-approved drug, device or biologic for which an IND or IDE is required? Is it otherwise regulated by FDA?

9 Is it otherwise regulated by FDA? Does your device research assess the safety or effectiveness of an FDA-approved device? If Yes, the research is subject to FDA research regulations. If No, the research possibly may not be subject to these regulations. Does your research involve the use of an FDA approved and marketed drug/biologic in the course of medical practice? If Yes, then the use of the drug/biologic is not subject to FDA research regulations.

10 Why Must You and the IRB Determine This? Because the Common Rule offers many more options for exemption than FDA regulations do.

11 Exemption Criteria in Common Rule (45 CFR (b)(1-6)).101(b)(1) Research conducted in established or commonly accepted educational settings, involving normal educational practices, such as (i) research on regular and special education instructional strategies, or (ii) research on the effectiveness of or the comparison among instructional techniques, curricula, or classroom management methods.

12 Exemption Criteria in Common Rule (45 CFR (b)(1-6)).101(b)(2) Research involving the use of educational tests (cognitive, diagnostic, aptitude, achievement), survey procedures, interview procedures or observation of public behavior, unless: (i) information obtained is recorded in such a manner that human subjects can be identified, directly or through identifiers linked to the subjects; *AND* (ii) any disclosure of the human subjects' responses outside the research could reasonably place the subjects at risk of criminal or civil liability or be damaging to the subjects' financial standing, employability, or reputation. *My emphasis*

13 Exemption Criteria in Common Rule (45 CFR (b)(1-6)).101(b)(3) Research involving the use of educational tests (cognitive, diagnostic, aptitude, achievement), survey procedures, interview procedures, or observation of public behavior that is not exempt under paragraph (b)(2) of this section, if: (i) the human subjects are elected or appointed public officials or candidates for public office; or (ii) federal statute(s) require(s) without exception that the confidentiality of the personally identifiable information will be maintained throughout the research and thereafter.

14 Exemption Criteria in Common Rule (45 CFR (b)(1-6)).101(b) (4) Research involving the collection or study of *existing* data, documents, records, pathological specimens, or diagnostic specimens, if these sources are publicly available or *if the information is recorded by the investigator in such a manner that subjects cannot be identified, directly or through identifiers linked to the subjects*. *Emphasis added*

15 Exemption Criteria in Common Rule (45 CFR (b)(1-6)).101(b)(5) Research and demonstration projects which are conducted by or subject to the approval of *FEDERAL* department or agency heads, and which are designed to study, evaluate, or otherwise examine: (i) Public benefit or service programs; (ii) procedures for obtaining benefits or services under those programs; (iii) possible changes in or alternatives to those programs or procedures; or (iv) possible changes in methods or levels of payment for benefits or services under those programs. *My addition*

16 Exemption Criteria in Common Rule (45 CFR (b)(1-6)).101(b) (6) Taste and food quality evaluation and consumer acceptance studies, (i) if wholesome foods without additives are consumed or (ii) if a food is consumed that contains a food ingredient at or below the level and for a use found to be safe, or agricultural chemical or environmental contaminant at or below the level found to be safe, by the Food and Drug Administration or approved by the Environmental Protection Agency or the Food Safety and Inspection Service of the U.S. Department of Agriculture.

17 Which of the 6 exemption criteria under the Common Rule also apply to FDA-regulated research? Please don t all speak at once!

18 Exemption Criteria in Common Rule (45 CFR (b)(1-6)).101(b) (6) Taste and food quality evaluation and consumer acceptance studies, (i) if wholesome foods without additives are consumed or (ii) if a food is consumed that contains a food ingredient at or below the level and for a use found to be safe, or agricultural chemical or environmental contaminant at or below the level found to be safe, by the Food and Drug Administration or approved by the Environmental Protection Agency or the Food Safety and Inspection Service of the U.S. Department of Agriculture.

19 Please Note None of the above exemption criteria apply to research involving prisoners. Exemption criteria 1-5 do not apply to FDA regulated research. The exemption 45 CFR (b)(2) does not apply to research involving children except for research involving observations of public behavior when the investigator does not participate in the activities being observed.

20 Exemption Criteria in Common Rule (45 CFR (b)(1-6)) re. Children.101(b)(2) Research involving the use of educational tests (cognitive, diagnostic, aptitude, achievement), *[survey procedures, interview procedures]* or observation of public behavior *and the investigator only observes*, unless: (i) and information obtained is recorded in such a manner that human subjects can be identified, directly or through identifiers linked to the subjects; AND (ii) any disclosure of the human subjects' responses outside the research could reasonably place the subjects at risk of criminal or civil liability or be damaging to the subjects' financial standing, employability, or reputation. *My addition*

21 Exemption Criteria for FDA Regulated Research 21 CFR (a) Any investigation which commenced before July 27, 1981 and was subject to requirements for IRB review under FDA regulations before that date, provided that the investigation remains subject to review of an IRB which meets the FDA requirements in effect before July 27, (b) Any investigation commenced before July 27, 1981 and was not otherwise subject to requirements for IRB review under Food and Drug Administration regulations before that date.

22 Exemption Criteria for FDA Regulated Research 21 CFR (c) Emergency use of a test article, provided that such emergency use is reported to the IRB within 5 working days. Any subsequent use of the test article at the institution is subject to IRB review. This must not meet the DHHS definition of research and involve human subjects.

23 Exemption Criteria for FDA Regulated Research 21 CFR (d) Taste and food quality evaluations and consumer acceptance studies, if wholesome foods without additives are consumed or if a food is consumed that contains a food ingredient at or below the level and for a use found to be safe, or agricultural, chemical, or environmental contaminant at or below the level found to be safe, by the Food and Drug Administration or approved by the Environmental Protection Agency or the Food Safety and Inspection Service of the U.S. Department of Agriculture.

24 Please Note Activities involving use of a drug, biologic or medical device will not be eligible for exemption from IRB review unless: the activity falls within 21 CFR , or the activity involves the use of an FDA approved drug, biologic or medical device in the course of medical practice (no safety or effectiveness assessment)

25 Also Please Note Activities involving the use of a drug, biologic or medical device for which the data will be submitted to or held for inspection by the FDA for regulatory purposes are not eligible for exemption from IRB review.

26 Exemption From What??and/or By Whom? Scrutiny by anyone? SBR review? CRSO review? CTQA audit? IRB review?

27 John M. Falletta, MD Senior Chairman, Institutional Review Board Duke University Health System Box 2712 Durham, NC

HUMAN SUBJECTS RESEARCH PROTOCOLS

HUMAN SUBJECTS RESEARCH PROTOCOLS HUMAN SUBJECTS RESEARCH PROTOCOLS Guidelines and Application Instructions Institutional Review Board (IRB), Office of Sponsored Programs and Research (OSPR) Determine the Type of IRB Review that is Required

More information

Radiation - Florida Department of Health Institutional Review Board

Radiation - Florida Department of Health Institutional Review Board 500-26 Radiation 500-26 Radiation - Florida Department of Health Institutional Review Board Protocol title: Researcher: Application contact: For questions, concerns, to provide input, or request a consultation,

More information

Human Research Protection Program. Investigator Manual

Human Research Protection Program. Investigator Manual Human Research Protection Program Revised July 7, 2014 HRP-910 7/7/2014 2 of 10 Table of Contents What is the purpose of this manual?... 3 What is Human Research?... 3 What is the Human Research Protection

More information

Tip Sheet 17: Review of Research by the Expedited Procedure

Tip Sheet 17: Review of Research by the Expedited Procedure Tip Sheet 17: Review of Research by the Expedited Procedure Related Accreditation Elements: II.2.E. Policies and procedures should describe review using the expedited procedure, when an expedited procedure

More information

Human Research Protection Program Guidance for Human Research Determination

Human Research Protection Program Guidance for Human Research Determination Human Research Protection Program Guidance for Human Research Determination I.1.A The sole purpose of the Institutional Review Board (IRB), as defined in federal statutes, is the protection of human subjects

More information

Human Research Protection Program. Plan

Human Research Protection Program. Plan Human Research Protection Program Plan Dated: September 4, 2014 HRP-101 9/4/2014 2 of 14 Table of Contents Scope... 3 Purpose... 3 Definitions... 3 Agent... 3 Clinical Trial... 3 Engaged in Human Research...

More information

What is an IRB (Institutional Review Board)?

What is an IRB (Institutional Review Board)? What is an IRB (Institutional Review Board)? The Belmont Report The Belmont Report on the Ethical Principles and Guidelines for the Protection of Human Subjects of Research was prepared by the National

More information

2 : self-directing freedom and especially moral independence 3 : a self-governing state

2 : self-directing freedom and especially moral independence 3 : a self-governing state A Adverse Effect Adverse Event AE Amendment Approve Approve Pending Assent Assurance Authorization Autonomy Unanticipated problem or unfavorable symptom or disease occurring during a clinical study, though

More information

Rules of Human Experimentation

Rules of Human Experimentation Rules of Human Experimentation Elaine Larson CUMC IRB Chair Associate Dean for Research, School of Nursing Professor of Epidemiology, Mailman School of Public Health Oversight for Human Research Office

More information

TOP 10 INVESTIGATOR RESPONSIBILITIES WHEN CONDUCTING HUMAN SUBJECTS RESEARCH

TOP 10 INVESTIGATOR RESPONSIBILITIES WHEN CONDUCTING HUMAN SUBJECTS RESEARCH Investigators Responsibility #1: Design and Implement Ethical Research Consistent with the Three Ethical Principles Delineated in The Belmont Report. The Belmont Report: Three Basic Ethical Principles:

More information

Expedited Review of Human Subject Research

Expedited Review of Human Subject Research Expedited Review of Human Subject Research Table of Contents Eligibility for Expedited Review Expedited Review IRB Oversight of Expedited Review Research Categories Eligible for Expedited Review Review

More information

Outline of Discussion

Outline of Discussion This final rule is intended to better protect human subjects involved in research, while facilitating valuable research and reducing burden, delay, and ambiguity for investigators. These revisions are

More information

Institutional Review Board for the Protection of Human Subjects

Institutional Review Board for the Protection of Human Subjects University of Michigan Deep Blue deepblue.lib.umich.edu 2012-10-16 Institutional Review Board for the Protection of Human Subjects Rosenzweig, Merle; Zeylikovich, Irina http://hdl.handle.net/2027.42/94130

More information

S A I N T M A RY S E M I N A RY O C T O B E R 1 9,

S A I N T M A RY S E M I N A RY O C T O B E R 1 9, IRB BASICS FOR ADMINISTRATORS S A I N T M A RY S E M I N A RY O C T O B E R 1 9, 2 0 1 6 JOHN CARROLL UNIVERSITY Catherine Anson, MA, CRA, CIM Director of Sponsored Research Assistant IRB Chair Carole

More information

The Revised Common Rule. Ann Johnson, PhD, MPH IRB Director University of Utah

The Revised Common Rule. Ann Johnson, PhD, MPH IRB Director University of Utah The Revised Common Rule Ann Johnson, PhD, MPH IRB Director University of Utah Objectives Describe the Changes that Affect the UU IRB What does this mean for ERICA? UPDATE: The postponement to January 2019

More information

Research Involving Human Data or Specimens

Research Involving Human Data or Specimens Page 1 of 5 Research Involving Human Data or Specimens Introduction: The Office for Human Research Protections has issued guidance on research involving coded private information or human biological specimens.

More information

Research: Ethics, Informed Consent, FDA, Off Label Use

Research: Ethics, Informed Consent, FDA, Off Label Use Research: Ethics, Informed Consent, FDA, Off Label Use Nasim Hedayati, MD, FACS, RPVI Assistant Professor Division of Vascular and Endovascular Surgery University of California, Davis 2015 Phlebology Review

More information

Oklahoma City University s IRB Procedures and Guidelines

Oklahoma City University s IRB Procedures and Guidelines Oklahoma City University s IRB Procedures and Guidelines The authority for evaluating research involving human subjects conducted on the Oklahoma City University campus or by Oklahoma City University employees

More information

Basics of Human Subjects Research INSTITUTIONAL REVIEW BOARD OFFICE OF RESEARCH CONTRACTS

Basics of Human Subjects Research INSTITUTIONAL REVIEW BOARD OFFICE OF RESEARCH CONTRACTS Basics of Human Subjects Research INSTITUTIONAL REVIEW BOARD OFFICE OF RESEARCH CONTRACTS Presentation Outline What is human subjects research? What are the reasons for IRB review? What is exempt from

More information

Quality Assurance for the Research Team: Connecting Day-to-Day Operations to a Regulatory Framework

Quality Assurance for the Research Team: Connecting Day-to-Day Operations to a Regulatory Framework 1 Quality Assurance for the Research Team: Connecting Day-to-Day Operations to a Regulatory Framework Mandy Morneault Research Compliance Monitor University of Washington Institute of Translational Health

More information

Top Ten Investigator Responsibilities When Conducting Human Subjects Research

Top Ten Investigator Responsibilities When Conducting Human Subjects Research Top Ten Investigator Responsibilities When Conducting Human Subjects Research Thanks to Ada Sue Selwitz, Univ. of Kentucky and PRIM&R (Public Responsibility in Medicine & Research) Investigator Responsibility

More information

WCG ACADEMY COURSE OVERVIEW

WCG ACADEMY COURSE OVERVIEW WCG ACADEMY COURSE OVERVIEW Investigator Course Title Documentation of Informed Consent Duration Ethical Principles Underlying Consent Documentation Long Form Short Form Consent Records Special Considerations

More information

Stanford University IRB Guidance On Data and Tissue Repositories

Stanford University IRB Guidance On Data and Tissue Repositories Stanford University IRB Guidance On Data and Tissue Repositories Databases, registries (data banks), and repositories (tissue banks) all involve the collection and storage of information and/or biological

More information

Streamlining IRB Procedures for Expanded Access

Streamlining IRB Procedures for Expanded Access Streamlining IRB Procedures for Expanded Access Marjorie A. Speers, Ph.D. Executive Director, WCG Foundation Richard Klein Director, FDA Patient Liaison Program Office of Health and Constituent Affairs

More information

Trends in Oversight of Human Research Protections?

Trends in Oversight of Human Research Protections? Trends in Oversight of Human Research Protections? Greg Koski, PhD, MD Associate Professor, Harvard Medical School Senior Scientist, James Mongan Institute for Health Policy Former Director, Office for

More information

INVESTIGATIONAL DEVICE EXEMPTION APPLICATION. IDE Title (if title being used)

INVESTIGATIONAL DEVICE EXEMPTION APPLICATION. IDE Title (if title being used) INVESTIGATIONAL DEVICE EXEMPTION APPLICATION IDE Title (if title being used) Name of Sponsor Investigator, MD X Professor, Department Icahn School of Medicine at Mount Sinai Date of Submission Form version

More information

Good Clinical Practice Handbook

Good Clinical Practice Handbook Division of Microbiology and Infectious Diseases Good Clinical Practice Handbook National Institute of Allergy and Infectious Diseases National Institutes of Health Department of Health and Human Services

More information

Applicability of US Regulations to Canadian Research

Applicability of US Regulations to Canadian Research Applicability of US Regulations to Canadian Research Mary Kate Needler Capital District Health Authority Halifax, Nova Scotia, Canada N2 Stakeholder Meeting August 18, 2014 MK s Conventions: 1. US Regulation

More information

Institutional Review Board Compliance Elizabeth City State University

Institutional Review Board Compliance Elizabeth City State University Institutional Review Board Compliance Elizabeth City State University Michelle Moore, MBA Research Compliance Officer/IRB Administrator Office of Sponsored Programs, Contracts & Grants 110 McLendon Hall

More information

50 SHADES OF GRAY: WHY AND WHEN IS IRB APPROVAL REQUIRED?

50 SHADES OF GRAY: WHY AND WHEN IS IRB APPROVAL REQUIRED? 50 SHADES OF GRAY: WHY AND WHEN IS IRB APPROVAL REQUIRED? Kevin L. Nellis, MS, CIP Executive Director, Human Research Protections and Quality Assurance Kathleen E. Powderly, CNM, PhD Director, John Conley

More information

Final Rule Material: Secondary Research with Identifiable Information and Biospecimens

Final Rule Material: Secondary Research with Identifiable Information and Biospecimens 2017 Biomedical Research Alliance of New York LLC CITI Program is a division of BRANY Final Rule Material: Secondary Research with Identifiable Information and Biospecimens www.citiprogram.org Content

More information

Please note that these flowcharts and checklists are from the IRB Researcher Manual.

Please note that these flowcharts and checklists are from the IRB Researcher Manual. Hello Researcher: Please use the following flowcharts and checklists to help you determine when your research may require a review by the Institutional Review Board (IRB). Please note that these flowcharts

More information

Expanded Access (including Emergency Use & Humanitarian Use Devices)

Expanded Access (including Emergency Use & Humanitarian Use Devices) Expanded Access (including Emergency Use & Humanitarian Use Devices) Bertha delanda, CIP IRB Training Specialist Research Compliance Office March 2012 What Is Expanded Access? Permits use of an investigational

More information

Institutional Review Board

Institutional Review Board Institutional Review Board Overview & Minimal Risk Research Jon Mark Hirshon, MD, MPH Vice-Chairman University of Maryland Institutional Review Board May 18, 2006 Jon Mark Hirshon, MD, MPH 1 Presentation

More information

PHS Human Subjects and Clinical Trials Information

PHS Human Subjects and Clinical Trials Information PHS Human Subjects and Clinical Trials Information OMB Number: 925-1 Expiration Date: 3/31/22 Please complete the human subjects section of the Research & Related Other Project Information form prior to

More information

Human Subjects Protection: Training for Research Teams

Human Subjects Protection: Training for Research Teams Human Subjects Protection: Training for Research Teams Walter L. Calmbach MD MPH South Texas Ambulatory Research Network (STARNet) Dept. of Family & Community Medicine Univ. of Texas Health Science Center

More information

Standard Operating Procedures Guidelines for Good Clinical Practice

Standard Operating Procedures Guidelines for Good Clinical Practice SOP # CRSC-105 Effective Date 10-22-2013 Version # 1 Version Date 7-30-2013 Standard Operating Procedures Guidelines for Good Clinical Practice Purpose: This SOP outlines the steps required to follow FDA

More information

Clinical Research at MSU

Clinical Research at MSU Financial Administration Development Program: Clinical Research at MSU Kristen Burt, Office of Regulatory Affairs (ORA) Sharon Schooley, Clinical & Translational Sciences Institute (CTSI) February 24,

More information

Please note that these flowcharts and checklists are from the IRB Researcher Manual.

Please note that these flowcharts and checklists are from the IRB Researcher Manual. Hello Researcher: Please use the following flowcharts and checklists to help you determine when your research may require a review by the Institutional Review Board (IRB). Please note that these flowcharts

More information

Guidance for IRBs, Clinical Investigators and Sponsors

Guidance for IRBs, Clinical Investigators and Sponsors Guidance for IRBs, Clinical Investigators and Sponsors IRB Responsibilities for Reviewing the Qualifications of Investigators, Adequacy of Research Sites, and the Determination of Whether an IND/IDE is

More information

Objectives Discuss the importance of proper data collection. Identify the types of data collected for clinical trials. List potential source documents

Objectives Discuss the importance of proper data collection. Identify the types of data collected for clinical trials. List potential source documents Data Management in Clinical Trials Introduction to the Principles and Practice of Clinical Research January 24, 2011 Diane St. Germain, RN, MS, CRNP Nurse Consultant Division of Cancer Prevention National

More information

REGIONAL HEALTH AUTHORITIES ACT

REGIONAL HEALTH AUTHORITIES ACT Province of Alberta REGIONAL HEALTH AUTHORITIES ACT Revised Statutes of Alberta 2000 Chapter R-10 Current as of June 17, 2014 Office Consolidation Published by Alberta Queen s Printer Alberta Queen s Printer

More information

Fourth Annual Pharmaceutical Regulatory and Compliance Congress

Fourth Annual Pharmaceutical Regulatory and Compliance Congress Fourth Annual Pharmaceutical Regulatory and Compliance Congress Preconference I A Compliance Primer for the Pharmaceutical Sector Michael P. Swiatocha November 12, 2003 Agenda for Preconference I Introduction

More information

Expanded Access and the Individual Patient IND

Expanded Access and the Individual Patient IND Expanded Access and the Individual Patient IND Research Wednesdays April 26, 2017 Erika Segear Johnson, PhD, RAC Associate Director of Regulatory Affairs Office of Regulatory Affairs and Quality Office

More information

VCU Faculty Held IND and IDE Procedure Handbook

VCU Faculty Held IND and IDE Procedure Handbook VCU Faculty Held IND and IDE Procedure Handbook Contents A. Introduction... 3 B. Purpose of Institutional Oversight... 3 C. Applicability... 4 D. University Oversight of Clinical Investigations Being Conducted

More information

Florida State University Policy 7-IRB-

Florida State University Policy 7-IRB- Florida State University Policy 7-IRB- Title of Policy: Institutional Review Board Jurisdiction/Applicability Responsible Executive: Gary K. Ostrander Approving Official: Gary K. Ostrander Effective Date:

More information

FDA Audit Preparation

FDA Audit Preparation Duke University Ethics and Compliance Office FDA Audit Preparation Margaret M. Groves, JD, CRA, CCRP, CHRC Director, CTQA Agenda External audits Best practices to get ready for audits 2 External Audits

More information

Copyright. Jeremiah J. Kelly (2015). All rights reserved. Further dissemination without express written consent strictly prohibited.

Copyright. Jeremiah J. Kelly (2015). All rights reserved. Further dissemination without express written consent strictly prohibited. Copyright. Jeremiah J. Kelly (2015). All rights reserved. Further dissemination without express written consent strictly prohibited. Special Review Designations & Approval Pathways Special Designations

More information

Study Start-Up SS STANDARD OPERATING PROCEDURE FOR Investigator Selection

Study Start-Up SS STANDARD OPERATING PROCEDURE FOR Investigator Selection Effective date of version: April 01, 2012 Study Start-Up SS 202.00 STANDARD OPERATING PROCEDURE FOR Investigator Selection Approval: Nancy M. Paris, MS, FACHE President and CEO 08 March 2012 (Signature

More information

EIGHT BASIC ELEMENTS OF INFORMED CONSENT

EIGHT BASIC ELEMENTS OF INFORMED CONSENT 1/6 This guidance addresses: o Eight Basic elements of informed consent o Additional elements of informed consent o Other information required by the IRB EIGHT BASIC ELEMENTS OF INFORMED CONSENT Required

More information

Compliance Department RESEARCH COMPLIANCE MEMORANDUM

Compliance Department RESEARCH COMPLIANCE MEMORANDUM Compliance Department RESEARCH COMPLIANCE MEMORANDUM To: UCD Health Chairs & Chief Administrator Officers From: Nirali Patel, Compliance Manager Kathy Olson, Research Compliance Analyst Re: Department

More information

Institutional Review Board

Institutional Review Board Institutional Review Board Policies and Procedures for the Protection of Human Subjects in Research Naval Medical Research Center Research Services Directorate Office of Research Administration Code 025,

More information

Ethical Oversight of Human Subject Research. Susan Burner Bankowski, MS,JD OHSU IRB Chair Director, Research Ethics Program

Ethical Oversight of Human Subject Research. Susan Burner Bankowski, MS,JD OHSU IRB Chair Director, Research Ethics Program Ethical Oversight of Human Subject Research Susan Burner Bankowski, MS,JD OHSU IRB Chair Director, Research Ethics Program Mandate of the IRB Review all research involving human subjects performed by OHSU

More information

Expanded Access. to Investigational Drugs & Biologics. for Treatment Use

Expanded Access. to Investigational Drugs & Biologics. for Treatment Use SJMHS Research Compliance Office Guidance Document Expanded Access to Investigational Drugs & Biologics for Treatment Use May 2015 1 Expanded Access to Investigational Drugs & Biologics for Treatment Use

More information

INVESTIGATOR HANDBOOK

INVESTIGATOR HANDBOOK INVESTIGATOR HANDBOOK INVESTIGATOR HANDBOOK Table of Contents MISSION... 3 FIRST TIME SUBMISSION... 3 EDUCATIONAL REQUIREMENTS... 3 PRINCIPAL INVESTIGATOR NEW STUDY SUBMISSIONS... 4 VULNERABLE POPULATIONS...

More information

ClinicalTrials.gov Registration Guide

ClinicalTrials.gov Registration Guide ClinicalTrials.gov Registration Guide The Food and Drug Administration Amendments Act (FDAAA), National Institutes of Health (NIH) and International Committee of Medical Journal Editors (ICMJE) require

More information

The Children s Hospital of Philadelphia Committees for the Protection of Human Subjects Policies and Procedures Determination of IND/IDE Requirement

The Children s Hospital of Philadelphia Committees for the Protection of Human Subjects Policies and Procedures Determination of IND/IDE Requirement Page: 1 of 8 I. PURPOSE II. III. IV. The purpose of this Standard Operating Procedure is to delineate when an investigator must obtain an Investigational New Drug (IND) or Investigational Device Exemption

More information

Ethical Principles in Clinical Research

Ethical Principles in Clinical Research Ethical Principles in Clinical Research Christine Grady NIH Clinical Center Department of Bioethics No conflicts of interest. Views presented are mine and do not necessarily represent positions or policies

More information

SITE SUBMISSION FORM (SINGLE SITE)

SITE SUBMISSION FORM (SINGLE SITE) *We accept study submissions by email, fax or mail. 1. STUDY INFORMATION A. Sponsor: Protocol.: Study Title: B. Study Type: Drug, Biologic or Dietary Supplement (please complete section C., then proceed

More information

Consent Language Does Affect Your Ability to Share

Consent Language Does Affect Your Ability to Share Consent Language Does Affect Your Ability to Share Tuesday, February 13, 2018 Jean Barone HRPO Director Melissa Miklos HRPO Associate Director Change in Education Units Continuing Education Units will

More information

Investigator Manual Revised August 19, 2013

Investigator Manual Revised August 19, 2013 Investigator Manual Revised August 19, 2013 Investigator Manual Page 2 of 31 Table of Contents What is the purpose of this manual?... 3 What is Human Research?... 3 What is the Human Research Protection

More information

Appropriate Role of Contractors Supporting the Government Working Group: Presentation of Recommendations 12/16/2005

Appropriate Role of Contractors Supporting the Government Working Group: Presentation of Recommendations 12/16/2005 PRELIMINARY WORKING GROUP DRAFT For Discussion Purposes Only Not Reviewed or Approved by the Acquisition Advisory Panel Appropriate Role of Contractors Supporting the Government Working Group: Presentation

More information

Ethical Principles in Clinical Research. Disclaimer. Christine Grady Department of Bioethics NIH Clinical Center

Ethical Principles in Clinical Research. Disclaimer. Christine Grady Department of Bioethics NIH Clinical Center Ethical Principles in Clinical Research Christine Grady Department of Bioethics NIH Clinical Center Disclaimer The views expressed are mine and do not necessarily represent the positions or policies of

More information

Human Research Protections Program Policies and Standard Operating Procedures

Human Research Protections Program Policies and Standard Operating Procedures Human Research Protections Program Policies and Standard Operating Procedures Version Date: April 2018 Presbyterian Healthcare Services Human Research Protections Office and Institutional Review Board

More information

The Nuremberg Doctor s Trial

The Nuremberg Doctor s Trial Research fundamentals Working with the institutional review board The Nuremberg Doctor s Trial that occurred at the end of World War II is generally cited as the event that drew attention to the need for

More information

Investigator Conflict of Interest Disclosure Policy for Human Subjects Research

Investigator Conflict of Interest Disclosure Policy for Human Subjects Research 55 Fogg Road South Weymouth Massachusetts 02190-2455 Investigator Conflict of Interest Disclosure Policy for Human Subjects Research PURPOSE OF POLICY Financial or other incentives may negatively impact

More information

8 Most Significant Proposed Changes to the Common Rule. Susan L. Rose Office for the Protection of Research Subjects (OPRS)

8 Most Significant Proposed Changes to the Common Rule. Susan L. Rose Office for the Protection of Research Subjects (OPRS) 8 Most Significant Proposed Changes to the Common Rule Susan L. Rose Office for the Protection of Research Subjects (OPRS) Overview 1. Informed Consent 2. Use of Biospecimens 3. Activities Excluded from

More information

\\NAS1\George\Docs\SoCRA\CCRP communications\study guide management

\\NAS1\George\Docs\SoCRA\CCRP communications\study guide management Five Content Areas Percent of Scored Test Items (Range) in Each Area This table shows the percent of scored test questions that are included in each major content area. Five Content Areas Ethical Principles

More information

IRB USE ONLY Approval Date: September 10, 2013 Expiration Date: September 10, 2014

IRB USE ONLY Approval Date: September 10, 2013 Expiration Date: September 10, 2014 Approval : September 10, 2013 Expiration : September 10, 2014 DESCRIPTION: You are invited to donate your leftover frozen eggs and/or ovarian tissues generated during your fertility preservation treatment

More information

Principal Investigator s Procedure Manual for the Protection of Human Subjects (June 2004)

Principal Investigator s Procedure Manual for the Protection of Human Subjects (June 2004) Downstate Medical Center State University of New York Institutional Review Board Principal Investigator s Procedure Manual for the Protection of Human Subjects (June 2004) Introduction Basic Principles

More information

Investigator Manual. Human Subjects Protection Program

Investigator Manual. Human Subjects Protection Program Human Subjects Protection Program HRP-103, Revised June 1, 2015 HRP-103 06/01/2015 2 of 33 Table of Contents Scope... 3 What is the purpose of this manual?... 3 What is Human Research?... 3 What is the

More information

Investigator Manual HRP-103

Investigator Manual HRP-103 HRP-103 Revised October 04, 2016 Table of Contents 1. Introduction... 3 A. Scope... 3 B. Purpose of this manual... 3 C. Where to get additional information and answers to questions... 3 E. Human Research

More information

Disclosure & Barring Service (DBS) Check Policy

Disclosure & Barring Service (DBS) Check Policy Disclosure & Barring Service (DBS) Check Policy Version: Final Author: HR Manager Date Issued: December 16 Date Approved by SMT: January 17 Impact Assessment Completed Yes Date of Next Review: January

More information

HRPP Policy No. 714 Effective Date 09/01/10 Revisions Date. Genome Wide Association Studies

HRPP Policy No. 714 Effective Date 09/01/10 Revisions Date. Genome Wide Association Studies Genome Wide Association Studies HRPP Policy No. 714 Effective Date 09/01/10 Revisions Date 1.0 Purpose This policy describes how investigators at the University of South Florida (USF) and USF Affiliates

More information

10/9/2012. Alicia Joy, IRB. Wednesday October 10, Please be sure to sign in and take copies of each handout.

10/9/2012. Alicia Joy, IRB. Wednesday October 10, Please be sure to sign in and take copies of each handout. Wednesday October 10, 2012 Please be sure to sign in and take copies of each handout. 1 Alicia Joy, IRB 2 FH Office of Research Administration Christina Jackson, BSN, RN, CCRC, CHRC 1 ClinicalTrials.gov

More information

Protection of Research Participants: The IRB Process and the Winds of Change

Protection of Research Participants: The IRB Process and the Winds of Change Protection of Research Participants: The IRB Process and the Winds of Change Ethics in Patient-Oriented Research October 12, 2011 Sharon Friend Director, OHRPP Overview Charge and Function of the IRB Quick

More information

HCCA: Compliance in Conducting Clinical Research: Conflict of Interest

HCCA: Compliance in Conducting Clinical Research: Conflict of Interest HCCA: Compliance in Conducting Clinical Research: Conflict of Interest Presented by Kendra Dimond, Esq. Epstein, Becker & Green, P.C. Washington, DC 202-861-4186 kdimond@ebglaw.com F. Lisa Murtha, J.D.

More information

Introduction to Clinical Research

Introduction to Clinical Research Introduction to Clinical Research What is Clinical Research? Clinical research is medical research that involves people like you. People volunteer to participate in carefully conducted investigations that

More information

GR Government Records

GR Government Records GR Government Record Series GR1000 GR1025 GR1050 GR1075 GR5750 GR5800 GR5825 Record Title PART 1: ADMINISTRATIVE RECORDS PART 2: FINANCIAL RECORDS PART 3: PERSONNEL AND PAYROLL RECORDS PART 4: SUPPORT

More information

1 The Clinical Research Coordinator (CRC)... 1

1 The Clinical Research Coordinator (CRC)... 1 TABLE OF CONTENTS Dedication... iii Introduction... xi 1 The Clinical Research Coordinator (CRC)... 1 Role and Responsibilities of the CRC...1 Personality and Skills... 3 Where Do CRCs Work?... 3 CRC Responsibilities...

More information

Office for Human Subject Protection. University of Rochester

Office for Human Subject Protection. University of Rochester POLICY 1. Purpose Outline the responsibilities and regulatory requirements when conducting human subject research that involves the use of drugs, agents, biological products, or nutritional products (e.g.,

More information

METHANEX CORPORATE MANUAL

METHANEX CORPORATE MANUAL SUB- 1.0 Scope All directors, officers and employees of Methanex Corporation and its subsidiaries ( Employee(s) ). 2.0 Purpose To provide Methanex Employees with: a) a set of standards meant to assist

More information

FDA-Regulated Research

FDA-Regulated Research Chapter 18: FDA-Regulated Research Chapter Contents 18.1 FDA-Regulated Research 18.2 Investigational Drugs 18.3 Investigational Medical Devices 18.4 Sponsor-Investigators 18.5 Humanitarian Use Devices

More information

The University of Texas Southwestern Medical Center Institutional Review Board Oversight Audit. Internal Audit Report 14:07

The University of Texas Southwestern Medical Center Institutional Review Board Oversight Audit. Internal Audit Report 14:07 Office of Internal Audit The University of Texas Southwestern Medical Center Institutional Review Board Oversight Audit Internal Audit Report 14:07 November 17, 2014 Table of Contents I. Executive Summary

More information

INSTITUTIONAL REVIEW BOARD (IRB) AT CALIFORNIA PACIFIC MEDICAL CENTER GUIDELINES FOR RESEARCH INVOLVING HUMAN SUBJECTS. Assurance Number: FWA

INSTITUTIONAL REVIEW BOARD (IRB) AT CALIFORNIA PACIFIC MEDICAL CENTER GUIDELINES FOR RESEARCH INVOLVING HUMAN SUBJECTS. Assurance Number: FWA INSTITUTIONAL REVIEW BOARD (IRB) AT CALIFORNIA PACIFIC MEDICAL CENTER GUIDELINES FOR RESEARCH INVOLVING HUMAN SUBJECTS Assurance Number: FWA00000921 California Pacific The Smith-Kettlewell University of

More information

FDA Audit Preparation

FDA Audit Preparation Duke University Office of Audit, Risk and Compliance (OARC) FDA Audit Preparation Margaret M. Groves, JD, CRA, CCRP, CHRC Associate Compliance Officer, Research Compliance Assurance (RCA) External audits

More information

Institutional Review Board (IRB)

Institutional Review Board (IRB) Institutional Review Board (IRB) Melissa Miklos Program Manager miklosm@upmc.edu Institutional Review Board What is the IRB? Why does the IRB exist? Where is the IRB? Who is the IRB? When do you need the

More information

Regulatory Protection of Human Subjects in Research

Regulatory Protection of Human Subjects in Research Chapter 2 Chapter Overview The protection of human subjects in research is paramount to any research effort. Research that involves human subjects is highly regulated by federal, state, and institutional

More information

Guidance for Sponsors, Institutional Review Boards, Clinical Investigators and FDA Staff

Guidance for Sponsors, Institutional Review Boards, Clinical Investigators and FDA Staff Guidance for Sponsors, Institutional Review Boards, Clinical Investigators and FDA Staff Guidance on Informed Consent for In Vitro Diagnostic Device Studies Using Leftover Human Specimens that are Not

More information

Kathy Weil Division of Bioresearch Monitoring Office of Compliance Center for Devices and Radiological Health US Food and Drug Administration

Kathy Weil Division of Bioresearch Monitoring Office of Compliance Center for Devices and Radiological Health US Food and Drug Administration Kathy Weil Division of Bioresearch Monitoring Office of Compliance Center for Devices and Radiological Health US Food and Drug Administration Kathy.Weil@fda.hhs.gov Follow the protocol and IDE regulations

More information

Role of the IRB in Human Subjects Research

Role of the IRB in Human Subjects Research Role of the IRB in Human Subjects Research Richard D. Stevenson, M.D. Chair Institutional Review Board for Health Sciences Research (IRB-HSR) University of Virginia Office of the Vice President for Research

More information

PREP Workshop # 20: Investigational Drug Accountability. Presented by: Ji-Eun Kim, Research Pharmacist Investigational Pharmacy Core, CRS

PREP Workshop # 20: Investigational Drug Accountability. Presented by: Ji-Eun Kim, Research Pharmacist Investigational Pharmacy Core, CRS PREP Workshop # 20: Investigational Drug Accountability Presented by: Ji-Eun Kim, Research Pharmacist Investigational Pharmacy Core, CRS CME Disclosure Statement The North Shore LIJ Health System adheres

More information

BOARD GUIDELINES ON SIGNIFICANT CORPORATE GOVERNANCE ISSUES

BOARD GUIDELINES ON SIGNIFICANT CORPORATE GOVERNANCE ISSUES BOARD GUIDELINES ON SIGNIFICANT CORPORATE GOVERNANCE ISSUES Management and the Board of Directors ( Board ) of Nabors Industries Ltd. (the Company ) are committed to conducting business consistent with

More information

EXPANDED ACCESS: RECENT LEGISLATION AND POLICY UPDATE

EXPANDED ACCESS: RECENT LEGISLATION AND POLICY UPDATE EXPANDED ACCESS: RECENT LEGISLATION AND POLICY UPDATE 21 st Century Cures and Beyond Policy and Regulatory Frameworks Shaping Early Access February 23, 2016 David J. Farber Partner King & Spalding LLP

More information

FDA > CDRH > CFR Title 21 Database Search

FDA > CDRH > CFR Title 21 Database Search Seite 1 von 7 FDA Home Page CDRH Home Page Search A-Z Index 510 (k) Registration Listing Adverse Events PMA Classification CLIA CFR Title 21 Advisory Committees Assembler Recalls Guidance Standards New

More information

provide leadership to the Company by practising ethical and sustainable decision making in the best interest of the Company and shareholders;

provide leadership to the Company by practising ethical and sustainable decision making in the best interest of the Company and shareholders; GUYANA GOLDFIELDS INC. BOARD OF DIRECTORS MANDATE PURPOSE 1. The Board of Directors (the Board ) is responsible for the stewardship of the business and affairs of Guyana Goldfields Inc. (the Company ).

More information

RESEARCH PERFORMANCE SITES AND COLLABORATIVE OFF-SITE RESEARCH

RESEARCH PERFORMANCE SITES AND COLLABORATIVE OFF-SITE RESEARCH 1. Overview RESEARCH PERFORMANCE SITES AND COLLABORATIVE OFF-SITE RESEARCH The ethical and regulatory requirements of The Ohio State University Human Research Protection Program (HRPP) apply to all research

More information

Institutional Review Board. HRP Investigator Manual

Institutional Review Board. HRP Investigator Manual Institutional Review Board HRP 103 - Investigator Manual Revised October 2015 Investigator Manual Page 2 of 50 Contents What is the purpose of this manual?... 4 What is Human Research?... 4 What is the

More information

University of Florida, Pediatric Integrated Care System. Compliance Program. Policy: Ped-I-Care Program Integrity Plan Number: CD-0003

University of Florida, Pediatric Integrated Care System. Compliance Program. Policy: Ped-I-Care Program Integrity Plan Number: CD-0003 University of Florida, Pediatric Integrated Care System Compliance Program Policy: Ped-I-Care Program Integrity Plan Number: CD-0003 Programs: Title XIX and Title XXI Effective Date: Title XIX January

More information

Technical Officer. SA Pathology. Woodville South TGO-0/ TGO-1

Technical Officer. SA Pathology. Woodville South TGO-0/ TGO-1 SA Health Job Pack Job Title Technical Officer Job Number 562425 Applications Closing 29 May 2015 Region / Division Health Service Location Classification Central Adelaide Local Health Network SA Pathology

More information